ST Winsan (shanghai) Medical Science And Technology Co., Ltd. provided preliminary earnings guidance for the first half of 2017. The company predicts a loss in the business performance in the first half of 2017, with the net loss belonging to shareholders of the company to be between RMB 30 million and RMB 34 million.